Irbesartanâ€™s effectiveness and safety are influenced by genetic interactions, where CYP2C9 variants impact its metabolism and plasma concentration, and variations in AGTR1 and other related genes like EDN1 and AGT affect its efficacy in blood pressure regulation. This understanding can aid in tailoring individual treatment plans in conditions like hypertension and diabetic nephropathy.